Talk:New Article Requests

Before You Submit a Proposal

GENERAL GUIDELINES: Your proposal should be concise, accurate, and well written. It will be reviewed by EyeWiki editors, who are practicing ophthalmologists. Spelling, grammar, and punctuation matter — your proposal reflects the quality you will bring to EyeWiki as a contributor.
- The EyeWiki policy on AI use applies to new article proposals as well as to published content. AI tools may be used solely to improve the readability and language of your work. They may not be used to replace essential research or writing tasks, including ideation, literature review, or drafting.
EVALUATION CRITERIA: Review these to be sure your proposal is eligible. The current acceptance rate for new articles is approximately 41%-43%.
EXISTING ARTICLES: Review these to see if your proposed topic is already included or could be included in an existing EyeWiki article. You can do this by performing a thorough search using various related key terms.
- If you find a pre-existing stand-alone article that addresses your topic or an article that includes your topic please edit the article to include your own input. You will be automatically recognized as a contributor to that article.
- Of those proposals that are not accepted, 85% are rejected because the topic is already covered or could be covered in an existing EyeWiki article.
PROPOSALS PREVIOUSLY SUBMITTED: Review these and please do not resubmit these topics. If there is substantial new evidence that has to come to light since the last proposal was rejected, you may resubmit a topic citing the new evidence to support a stand-alone EyeWiki article.
PREAPPROVED TOPICS and ARTICLES NEEDING REVISION: Can't think of a topic for a new article? Consider revising topics on this list of articles flagged by the editorial board for revisions. Visit the discussion pages of these articles to find out what is needed. No approval is necessary to revise these articles. Currently, there are some new suggested topics that have been preapproved for stand-alone articles. Contact eyewiki@aao.org if you would like to work on one of the pre-approved new articles and can complete it within 30 days.

Instructions

IMPORTANT: Review the section above "Before You Submit a Proposal"
Click the "Add topic" link to create a new proposal on this page not in your own talk page.
Then add the relevant list items as shown
- Title: Enter this in the Subject field
- Summary: Please provide some details about what will be covered and why you think the article would benefit EyeWiki. Do not submit a complete article. Very rarely EyeWiki editors may request additional information beyond your proposal; in most cases this is not necessary.
- Section: Indicate what subspecialty section the article should be added to. You may indicate up to 2 sections.
- Submitted by: Name of the ophthalmologist submitting the proposal. Sign and date your request by entering 4 tilde ~ characters only. This will automatically add your username, a time stamp and a link to your profile. You will see this after you save the page.
  - SAMPLE: Rayna.Ungersma.AAO (talk) 10:01, April 30, 2024 (PDT)
Click: SAVE at the bottom of the page

Sample Proposal

Biosimilars in Ophthalmology
Summary: Patents for original biologics used to treat nAMD and DME are approaching expiration. Numerous companies are striving to replicate these biologics as biosimilars, which are drugs that mimic the effects of the original biologic, but do not have the same active ingredients. This article will summarize the current literature about biosimilars and their safety, efficacy, and quality and provide an in-depth review of approved biosimilars as well as those that are in development. This article will provide EyeWiki readers with information about numerous alternatives for treatment nAMD and DME.
Section: Retina/Vitreous
Submitted by: Rayna.Ungersma.AAO (talk) 15:04, May 1, 2024 (PDT)

World’s First Polyfocal Progressive Intraocular Lens—Spirant Autofocus Pro IOL

Summary: The premium trifocal intraocular lenses (IOL) utilize refractive, diffractive, and non-diffractive wavefront shaping to correct distance, intermediate, and near vision. But these features lead to visual side effects like halos, glare, dysphotopsia, reduced contrast sensitivity, lower reading speed, minimized depth of focus, difficulty in night driving, and markedly reduced MTF values. This article will summarize the current literature about one of the ringless IOLs, the Spirant Autofocus Pro. This IOL is devoid of any rings and works on the principle of GRIN (Gradient Refractive Index) technology to correct the distance, intermediate, and near vision with high reading speed. Our article will provide an in-depth analysis of its unique optical design, real-world comparative performance, and long-term outcomes. This article will provide EyeWiki readers with all possible insights regarding this new IOL's ability to correct distance, intermediate, and near vision after cataract surgery and is free of all photic phenomena; have excellent depth of focus; have high MTF values; and is fit for night drivers. Section: Cataract Submitted by Arvind.Morya (talk) 07:06, May 16, 2026 (PDT)

Orthoptek Magnocellular Stimulator In Refractive Amblyopia

Summary:The therapy in vogue is conventional patching for refractive amblyopia, but this has a high recurrence rate of 25 to 50 %. The focus of recent research has been on the eye-brain ability to process motion, shape perception, spatial interaction, hyperacuity, contour integration, and binocular single vision (BSV) components that can also be treated without cumbersome patching therapy. The Orthoptek Magnocellular Stimulator has shown promise in enhancing visual outcomes and achieving faster and sustainable binocular function. Orthoptek is a non-invasive instrument used in the treatment of refractive amblyopia of different types and other ocular disorders, like nystagmus, 4th and 6th nerve palsies, loss of stereopsis, and cerebral palsy. While using this instrument, there is a sequential stimulation of the magnocellular pathway and parvocellular pathway. This top-down impulse releases the nitric oxide in the visual area, leading to fast recuperation from suppression, even in older age groups. The visual improvement is noticed subjectively by the patients after the first or second session of treatment. This article will provide EyeWiki readers with information about this new and novel modality for the management of refractive amblyopia in correcting all elements of binocular single vision at any eye care setting. Section: Neuroophthalmology Submitted by Arvind.Morya (talk) 07:06, May 16, 2026 (PDT)

Per- and Polyfluoroalkyl Substances (PFAS) in Ophthalmologic Disease

Summary: Per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” are persistent environmental pollutants increasingly linked to systemic and ocular disease. Emerging epidemiologic and mechanistic evidence suggests associations between PFAS exposure and multiple ophthalmologic conditions, including age-related macular degeneration (AMD), cataracts, vitreous disorders, visual impairment, and developmental myopia. Proposed mechanisms include oxidative stress, chronic inflammation, lipid dysregulation, extracellular matrix remodeling, and hormonal disruption affecting ocular growth and aging. This article will provide EyeWiki readers information regarding the current literature of PFAS-associated ocular disease and provide an overview of the biologic mechanisms underlying these associations. Additionally, this article will discuss clinical implications, public health considerations, patient counseling strategies for PFAS exposure reduction, and future research directions regarding the role of PFAS in opthalmology. Section: Miscellaneous Submitted by: Safa.Ibrahim (talk) 21:41, May 18, 2026 (PDT)

Nitrosative Stress in Ophthalmology

Summary: Nitrosative stress results from excessive production of reactive nitrogen species (RNS), including nitric oxide and peroxynitrite. Nitrosative stress can disrupt cellular signaling and induce oxidative protein modification, mitochondrial dysfunction, and general inflammation. Although nitric oxide plays essential roles in ocular function, dysregulated nitric oxide metabolism may be implicated in the pathogenesis of major ophthalmologic diseases. Emerging evidence links nitrosative stress to age-related macular degeneration, diabetic retinopathy, glaucoma, keratopathy, and cataract formation. This article will provide EyeWiki readers a summary of the current literature regarding the mechanisms, ocular complications, and biomarkers, such as 3-nitrotyrosine, of nitrosative stress in ophthalmology. This article will also discuss management strategies for nitrosative stress, including nitric oxide-modulating drugs, antioxidant therapy, and tyrosine kinase inhibitors. Section: Miscellaneous Submitted by: Safa.Ibrahim (talk) 21:43, May 18, 2026 (PDT)